New Cancer Immunotherapy Opdivo Approved by FDA December 22, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD
Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer January 13, 2015December 14, 2022 Matthew Tontonoz